Biotechnology Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune Why Alpine Immune Sciences Stock Is Trading Higher Today? – Alpine Immune Sciences (NASDAQ:ALPN), Vertex Pharmaceuticals (NASDAQ:VRTX) Read more
Biotechnology Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck’s Pneumococcal Shots – Analyst Says – Vaxcyte (NASDAQ:PCVX) Read more
Biotechnology This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO – Regenxbio (NASDAQ:RGNX) Read more
Biotechnology Gene Therapy Player REGENXBIO’s RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst – Regenxbio (NASDAQ:RGNX) Read more